Abd Alla Mohamed Darwish Ahmed, Elibiary Saleh Ahmed, Wu George Y, El-Awady Mostafa Kamel
Tropical Medicine Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Department of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, CT, USA.
J Clin Transl Hepatol. 2017 Dec 28;5(4):319-326. doi: 10.14218/JCTH.2017.00034. Epub 2017 Sep 7.
Occult HCV infections (OCIs) include IgG antibody seronegative cryptogenic (COCIs), as well as seropositive secondary naïve (SNOCIs) and experienced (SEOCIs) cases. We used peripheral-blood-mononuclear-cell (PBMC)-PCR to evaluate COCIs and SNOCIs prevalence, serum HCV spontaneous disappearance (SCSD) in naïve cirrhotics and non-cirrhotics, intra-PBMC HCV-RNA strands in relation to cirrhosis density in naïve non-viremia cases, and HCV-RNA seroconversion after 1 year of solitary naïve intra-PBMC infection. The anti-HCV IgG antibody-positive naïve-patients ( = 785) were classified into viremic ( = 673) and non-viremic [ = 112, including non-cirrhotics ( = 55) and cirrhotics ( = 57)], and 62 controls without evidence of HCV-infection. Controls and post-HCV non-viremia cases ( = 62+112 = 174) were submitted to hepatic Fibroscan-Elastography evaluation. All subjects ( = 847) were screened for intra-PBMC HCV-RNA sense and antisense strands by nested-PCR. Naïve-OCI cases (4.84%) that were diagnosed by PBMC-PCR significantly raised the total numbers of HCV-infection to 714 ( = 0.01). The percent positivity of SNOCIs (34.82%) was significantly higher than for asymptomatic-COCIs (3.125%, = 0.0001). Comparing PBMC-PCR with single-step-reverse-transcription (SRT)-PCR for identification of SCSD in naïve IgG antibody-positive non-viremia patients ( = 112) revealed a decline in SCSD prevalence by PBMC-PCR (from 14.27% to 9.3%), regardless of presence of hepatic cirrhosis ( = 0.03). SCSD was found to be higher by PBMC-PCR in non-cirrhotics compared to cirrhotics ( = 0.0001), with an insignificant difference when using SRT-PCR ( = 0.45). Intra-PBMC HCV-RNA infection was significantly more frequent in cirrhotics compared to both non-cirrhotics and controls ( < 0.0005). An increased hepatic fibrosis density was recognized in intra-PBMC HCV-RNA infection with sense ( = 0.0001) or antisense strand ( = 0.003). HCV-RNA seroconversion was associated with intra-PBMC infection when both sense and antisense strands were detected ( = 0.047). Intracellular HCV-RNA evaluation is crucial for diagnosing OCIs and addressing relapse probability.
隐匿性丙型肝炎病毒感染(OCI)包括IgG抗体血清学阴性的隐源性感染(COCI),以及血清学阳性的初治(SNOCI)和经治(SEOCI)病例。我们采用外周血单个核细胞(PBMC)-PCR来评估COCI和SNOCI的患病率、初治肝硬化患者和非肝硬化患者血清丙型肝炎病毒自发清除(SCSD)情况、初治无病毒血症患者PBMC内丙型肝炎病毒RNA链与肝硬化程度的关系,以及单纯PBMC内初治感染1年后丙型肝炎病毒RNA血清学转换情况。抗丙型肝炎病毒IgG抗体阳性的初治患者(n = 785)被分为病毒血症组(n = 673)和无病毒血症组[n = 112,包括非肝硬化患者(n = 55)和肝硬化患者(n = 57)],以及62名无丙型肝炎病毒感染证据的对照者。对照者和丙型肝炎病毒感染后无病毒血症病例(n = 62 + 112 = 174)接受肝脏Fibroscan弹性成像评估。通过巢式PCR对所有受试者(n = 847)进行PBMC内丙型肝炎病毒RNA正负链筛查。通过PBMC-PCR诊断的初治OCI病例(4.84%)显著提高了丙型肝炎病毒感染总数至714例(P = 0.01)。SNOCI的阳性率(34.82%)显著高于无症状COCI(3.125%,P = 0.0001)。比较PBMC-PCR与单步逆转录(SRT)-PCR用于识别初治IgG抗体阳性无病毒血症患者(n = 112)的SCSD情况,发现PBMC-PCR使SCSD患病率下降(从14.27%降至9.3%),无论是否存在肝硬化(P = 0.03)。与肝硬化患者相比,PBMC-PCR检测发现非肝硬化患者的SCSD更高(P = 0.0001),而使用SRT-PCR时差异无统计学意义(P = 0.45)。与非肝硬化患者和对照者相比,肝硬化患者PBMC内丙型肝炎病毒RNA感染明显更频繁(P < 0.0005)。在PBMC内丙型肝炎病毒RNA感染中,正链(P = 0.0001)或负链(P = 0.003)感染时肝脏纤维化程度增加。当同时检测到正负链时,丙型肝炎病毒RNA血清学转换与PBMC内感染相关(P = 0.047)。细胞内丙型肝炎病毒RNA评估对于诊断OCI和确定复发概率至关重要。